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ABSTRACT
Objective To determine whether a decision aid designed
for adults with low education and literacy can support
informed choice and involvement in decisions about
screening for bowel cancer.
Design Randomised controlled trial.
Setting Areas in New South Wales, Australia identified as
socioeconomically disadvantaged (low education
attainment, high unemployment, and unskilled
occupations).
Participants572adultsagedbetween55and64withlow
educational attainment, eligible for bowel cancer
screening.
Intervention Patient decision aid comprising a paper
based interactive booklet (with and without a question
prompt list) and a DVD, presenting quantitative risk
information on the possible outcomes of screening using
faecal occult blood testing compared with no testing. The
control group received standard information developed
for the Australian national bowel screening programme.
Allmaterialsandafaecaloccultbloodtestkitwereposted
directly to people’s homes.
Main outcome measures Informed choice (adequate
knowledge and consistency between attitudes and
screening behaviour) and preferences for involvement in
screening decisions.
Results Participants who received the decision aid
showed higher levels of knowledge than the controls; the
mean score (maximum score 12) for the decision aid
group was 6.50 (95% confidence interval 6.15 to 6.84)
and for the control group was 4.10 (3.85 to 4.36;
P<0.001). Attitudes towards screening were less positive
in the decision aid group, with 51% of the participants
expressing favourable attitudes compared with 65% of
participants in the control group (14% difference, 95%
confidence interval 5% to 23%; P=0.002). The
participation rate for screening was reduced in the
decision aid group: completion of faecal occult blood
testing was 59% v 75% in the control group (16%
difference, 8% to 24%; P=0.001). The decision aid
increased the proportion of participants who made an
informedchoice,from 12% in the controlgroup to 34% in
the decision aid group (22% difference, 15% to 29%;
P<0.001).More participants in the decision aidgroup had
no decisional conflict about the screening decision
compared with the controls (51% v 38%; P=0.02). The
groups did not differ for general anxiety or worry about
bowel cancer.
ConclusionsTailoreddecisionsupportinformationcanbe
effective in supporting informed choices and greater
involvement in decisions about faecal occult blood
testing among adults with low levels of education,
without increasing anxiety or worry about developing
bowel cancer. Using a decision aid to make an informed
choice may, however, lead to lower uptake of screening.
Trial registration ClinicalTrials.gov NCT00765869 and
Australian New Zealand Clinical Trials Registry
12608000011381.
INTRODUCTION
Engagingpatientsindecisionsabouttheirhealthcareis
promoted by leading health organisations,
1-3 with
growing importance placed on providing patients
with the best available evidence and encouraging
them to express their preferences in the decision mak-
ing process.
45 This has led to a demand for tools to
facilitate patients’ involvement in decision making
about their health care. Patient decision aids are inter-
ventions designed to help people make informeddeci-
sions about their health by providing information on
the options and possible outcomes relevant to their
own health. Typically decision aids contain numerical
and graphical risk information about the possible out-
comes of each choice, and exercises to help people
arriveatdecisionsthatreflecttheirpersonalvaluesand
preferences.
6 Cochrane reviews suggest that, com-
pared with usual care, decision aids improve knowl-
edge about clinical options, create more realistic
expectations about outcomes, and increase active
involvement in the decision making process.
7
However, despite a substantial increase in the avail-
abilityofdecisionaids(over270arecurrentlylistedon
theCochranedecisionaidregistryatwww.decisionaid.
ca/AZlist.html), few attempts have been made to
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disadvantagedpopulationsandthosewithlowliteracy.
Thesegroupsmaybeingreatestneedofinformationto
support their understanding and involvement in deci-
sion making, as limited literacy is adversely associated
witharangeofhealthrelatedoutcomes.Theseinclude
poor knowledge about disease and methods of early
diseaseprevention,highratesofemergencyadmission
to hospital,poor self care managementof chronic con-
ditions, and low satisfaction with doctor-patient
communication.
8
We tested the effectiveness of a decision aid in facil-
itating understanding, involvement, and informed
choice about participation in screening for bowel can-
ceramongasampleofparticipantswithloweducation.
Current guidelines from the UK General Medical
Councilstateclearlythatthedecisiontoscreenforcan-
cer should be based on an informed choice, in which
peoplearegivenclearandbalancedinformationabout
the benefits and harms of screening (including the
option of no screening).
910 Despite this, concern
remains about informed choice in screening, centring
on the conflict between two ethical principles: auton-
omy and utilitarianism. The first principle concerns
respecting patient autonomy and agency, whereby
people are free to choose whether or not they undergo
screening and are provided with information (on the
harms as well as the benefits) to make an informed
choice.Thesecondprinciple,utilitarianism,viewspar-
ticipation in screening as being in the public interest,
and high rates of uptake are seen as paramount for
improving population health. However, a strong case
has been made for greater honesty about the harms of
screening and for potential participants of screening
programmes to be given the opportunity to make an
informed choice.
1112
In the United Kingdom, Australia, and several Eur-
opeancountries,faecaloccultbloodtestingiscurrently
offered through national government funded pro-
grammes, with test kits posted directly to people’s
homes.
13Comparedwithothernationalscreeningpro-
grammes (for example, screening for breast and cervi-
cal cancer), the actual test and the decision to
participate are usually done at home, with minimal
interaction with a healthcare provider, and supported
mainly by written information.
We evaluated a decision aid for screening using fae-
cal occult blood testing developed for groups with low
education and literacy. Our primary interest was
whether the decision aid could support informed
choice and increase involvement in decisions about
screeningamongacommunitysamplewithloweduca-
tion. We further evaluated whether a question prompt
list—a structured list of questions about the benefits
and harms of bowel cancer screening that people may
want to ask their doctor—in addition to a decision aid,
enhanced decision making. Systematic reviews have
shown that question prompt lists may empower
patientstoaskquestions,buttheyhavenotbeentested
in a sample of people with low education.
14
METHODS
We carried out a randomised trial comprising three
arms,withparticipantsrandomisedtoeitheradecision
aid booklet with accompanying DVD, a decision aid
and DVD along with a question prompt list, or a stan-
dardconsumerinformationbooklet,developedaspart
of the Australian national bowel cancer screening pro-
gramme (control group). All participants received a
faecal occult blood test kit for self sampling.
Participants and recruitment
Potential participants were randomly drawn from the
New South Wales electoral register, using the Austra-
lian Bureau of Statistics SEIFA (Socio-Economic
IndexforArea)codestotargetareasidentifiedassocio-
economically disadvantaged (low educational attain-
ment, high unemployment, and unskilled
occupations).
15 The Australian Electoral Commission
randomly extracted a total of 8400 records from the
register.Adatabasecontainingnamesandphonenum-
bers was then provided to Hunter Valley Research
Foundation, which administered the recruitment and
follow-up interview surveys using a computer assisted
telephone interviewing system. The foundation is an
independent non-profit organisation, experienced in
running community surveys and recruiting partici-
pants into health and social research studies.It is listed
by the New South Wales Department of Health as an
approved provider of research services, and regularly
carries out telephone and face to face surveys for State
and Commonwealth health departments and aca-
demic institutions. Its interviewers are routinely
trainedtoensurebiasisnotintroducedintotheirinter-
views. In the current study interviewers followed a
standardised interview script and their performance
was monitored as part of standard quality assurance
processes by Hunter Valley Research Foundation.
The Foundation randomly selected potential respon-
dents from the database and contacted them by tele-
phone to determine their eligibility and to invite them
to take part in the study.
Men and women were eligible for the trial if they
were aged 55-64 (selected to match the target age
groupforthenationalprogramme),spokemainlyEng-
lish at home, had an average or slightly above average
risk of bowel cancer (family history risk, category 1
underexistingguidelines),
16andhadaloweducational
attainment—that is, no formal educational qualifica-
tions, intermediate school certificate (awarded for
completion of four years of high school or secondary
school), or trade certificate (roughly equivalent to UK
adults with a national vocational qualification or an
apprenticeship). The selection of these specific educa-
tional qualifications as eligibility criteria was based on
the results from the Australian Bureau of Statistics
adult literacy and life skills survey.
17 This national sur-
vey of adult literacy indicated these specific levels of
education were more likely to achieve lower literacy
scores for the proseand documentliteracy scales com-
pared with adults of higher education.
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familyhistoryofbowelcancer,hadcompletedabowel
cancer screening test or examination (including faecal
occult blood testing, flexible sigmoidoscopy, colono-
scopy) in the past two years, or had already been
invited to participate in the national programme or
any other bowel cancer screening scheme.
Once eligibility was confirmed, we administered a
baseline telephone questionnaire to record personal
characteristics, self reported health status, and self
reported functional health literacy, and to measure
knowledge of and interest in screening using faecal
occult blood testing. Participants who verbally con-
sented to take part were then randomised to one of
the three groups using random permuted blocks of
size 6 and 9 for each sex stratum. A statistician (JMS)
who had no contact with participants generated this
randomisation list. Interviewers responsible for
recruiting participants were not aware of the randomi-
sation sequence or allocation and therefore did not
know which intervention respondents would receive.
Oncompletionofthebaselineinterview,theappropri-
ate intervention (decision aids or government screen-
ing booklet) and corresponding studymaterials(faecal
occult blood test kit and instructions) were posted to
participants. Participants were recruited between July
and November 2008.
Interventions
Decision aid groups
Participants in the two decision aid groups received a
paperbasedbookletandDVD(withorwithoutaques-
tionpromptlist)thathadbeenspecificallydesignedfor
adults with low education and literacy skills. To
develop a decision aid that was more sensitive to the
needs of adults with low literacy, principles of plain
language and basic design were applied, together
with simple techniques to reduce cognitive effort for
the reader.
1819 Such strategies included reducing the
amount of text, replacing technical language with lay
language, creating a glossary of medical terms that
werehighlightedthroughoutthetext,simplifyingmed-
ical diagrams, using the active voice for communica-
tion, and providing contextual information before
factual information. Illustrations were also integrated
into the revised decision aid, based on research sug-
gesting that combining well designed pictures with
text enhances attention, recall, and understanding
among groups with lower literacy.
20 A combination
of cartoon-style images and anatomical diagrams of
the bowel were incorporated. A detailed description
of the development of the decision aid has been
published.
2122
The tool was designed to comply with the Inter-
national Patient Decision Aid Standard
23 and pre-
sented tailored risk information for different sex and
family history groups about the cumulative outcomes
of biennial screening with faecal occult blood testing.
This included mortality from bowel cancer (with and
without screening), the risk of false positives and false
negatives,intervalcancers,removalofpolypsdetected
bycolonoscopy,andbowelcancerdetectedbyscreen-
ing. A full version of the decision aids aimed at the
different sexes can be found at http://sydney.edu.au/
medicine/public-health/step/publications/decisio
naids.php.Thechanceofeachoutcomewasexpressed
asaneventrateper1000menor1000womenscreened
every two years over 10 years, using diagrams with
ovals to represent a population of 1000 (see web extra
appendix 1). One member of the research team (LT)
calculated the probabilities of these outcomes from
Australiannationaldata(AustralianInstituteofHealth
and Welfare and the Cancer Council of Australia) to
reflectthebestavailableevidenceatthetime.
24Theaid
also contained an interactive exercise for the reader to
identify their risk of bowel cancer (based on their
family history) and a personal worksheet to help
them clarify their values (see web extra appendix 2).
The content, design, and layout of the tool was
informedbyin-depthqualitativeinterviewswithadults
of varying levels of education and literacy skill. We
also consulted an expert panel comprising experts in
bowel cancer screening, general practitioners, experts
in adult literacy, and linguists.
Control group
Participants in the control group received the consu-
mer information booklet developed for people invited
to take part in the Australian national bowel cancer
screening programme. This booklet contained written
and numerical information about bowel cancer and
screening for bowel cancer. A bar chart was used to
present data on the most common causes of cancer
related deaths for men and women in Australia, and a
relative risk statement (“If you do a FOBT [faecal
occult blood test] every two years, you can reduce
your risk of dying from bowel cancer by up to one
third”) was used to state the efficacy of faecal occult
blood testing. Table 1 compares the key content and
design features of the booklets.
Outcome measures
Two weeks after the package had been posted to parti-
cipants they were telephoned to complete a follow-up
interview.Itwasnotpossiblefortheinterviewerstobe
blindedtothegroupallocation.However,allquestions
used standardised wording with pre-coded responses
and were asked within a supervised environment,
where interviewer performance was regularly moni-
tored to ensure scripts were read as written. Before
the main trial a pilot study was carried out with 36
respondents. Participants were recruited using the
same procedures described for the main trial, with
the objective of testing this recruitment strategy and
examining the wording and suitability of the baseline
and follow-up telephone interview surveys.
Primary outcome measures
The primary outcomes were informed choice and pre-
ferences for involvement in the screening decision.
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Informed choice was assessed using the multidimen-
sional model of informed choice, a measure that has
beendevelopedandvalidatedinthecontextofantena-
tal screening for Down’s syndrome.
2526 In the current
study we applied this measure to assess the extent to
which people made an informed choice about partici-
pating in screening using faecal occult blood testing.
To determine whether a participant had made an
informed (or uninformed) choice about such screen-
ing, we individually assessed, and then combined,
three constructs: knowledge about the possible out-
comesofscreening,attitudestowardsdoingthescreen-
ing test, and screening behaviour. Participants were
grouped into one of eight classifications according to
their knowledge about the outcomes of faecal occult
blood testing (adequate v inadequate), attitudes (posi-
tive v negative), screening behaviour (completed the
screening test v did not complete the screening test).
Participants were considered to have made an
informed choice to complete the screening test if they
had adequate knowledge and positive attitudes
towards the test. An informed choice to decline the
screening test occurred when a participant had a nega-
tive attitude towards the test, had adequate knowledge
aboutthe outcomes,and didnotcomplete the test.We
considered participants who had inadequate knowl-
edge or their attitudes did not reflect their actual
screening behaviour to have made an uninformed
choice about screening. This method of classification
is consistent with that applied by the researchersin the
original use of this measurement instrument.
2526
Knowledge
Developmentoftheknowledgemeasurewasinformed
by the UK General Medical Council guidelines relat-
ingtoscreening,whichrecommendthatpeopleshould
beawareofthepotentialforscreeningtopreventdeath
from bowel cancer, but also understand the potential
risks(includingthepossibilityoffalsepositiveandfalse
negative results).
9 We assessed participants’ concep-
tual knowledge to examine whether they understood
theunderlyingconcept(forexample,ofexperiencinga
false positive result as an outcome of screening), and
numerical knowledge to determine whether they were
aware of the approximate numbers of people affected
(for example, the likelihood of experiencing a false
positive result). Questions to assess knowledge were
asked using simple, jargon-free language and were
piloted with participants with low educational attain-
ment before the main trial. The knowledge measure
uses a similar approach to assessing knowledge as
used in previous research on screening decision aids
by our group.
27 The aim of this measure was to assess
both gist (conceptual) and detailed numerical (verba-
tim) understanding of the decision, both of which are
required to gain an overall understanding to inform
decisionmaking.Themeasureassessedunderstanding
of five core concepts relating to bowel cancer screen-
ing. These concepts were that the number of asympto-
matic men and women who die from bowel cancer
over the next 10 years is relatively small; deaths from
bowel cancer are reduced by screening, but the abso-
lute reduction in deaths attributable to screening is
small (a few per 1000 screened over 10 years); bowel
cancer screening may lead to false positive results; the
number of men and women who experience a false
positive result is relatively large (a few hundred out of
1000 screened over 10 years) comparedwith the num-
ber of lives saved by screening; and bowel cancer
screening sometimes misses cancers.
Wedevelopedamarkingschemeusinganapproach
similar to that of previous researchers.
27 It provided a
maximum score of 12 (4 marks for conceptual under-
standingand8fornumericalknowledge;seewebextra
appendix 3). We decided a priori that a pass mark of
Table 1 |Comparison between decision aid and government booklet
Component/feature Decision aid booklet Government booklet
General description Paper based, interactive (33 page) booklet (and accompanying DVD)
containing written and quantitative information about bowel cancer
and bowel cancer screening. Flesch-Kincaid readability score=grade 7
Paper based, 20 page bookletwithwritten and quantitative information
about bowel cancer and bowel cancer screening. Flesch-Kincaid
readability score=grade 9
Visual aspects Use of simplified text and bullet points. Glossary of medical terms.
Visual illustrations and cues. Medical diagram of bowel
Useofplainlanguage.Largeamountsoftextoneachpage.Photographs
of adults within target age range. Medical diagram of digestive system
Key factual content Purposeofcancerscreening—thatis,todetectbowelcanceratanearly
stage. Bowel cancer and its risk factors. Risk of bowel cancer based on
family history. Faecal occult blood testing procedure. Colonoscopy
procedure as follow-up investigation and associated risks
Purpose of cancer screening—that is, to detect bowel cancer at an early
stage. Bowel cancer and its risk factors. Faecal occult blood testing
procedure. Colonoscopy procedure as follow-up investigation and
associated risks
Use of tailored information Tailored risk information for age, sex, and family history groups about
cumulative outcomes of biennial screening using faecal occult blood
testing
None
Presentation of quantitative information Systematic 1000 oval diagrams (see web extra appendix 1) using
naturalfrequencies,timeframes,andconsistentdenominatorsusedto
convey:absoluteriskreductioninmortalityfrombowelcancerwith(and
without) biennial screening using faecal occult blood testing over
10 years; and probability of cumulative outcomes of screening using
faecal occult blood testing (including risk of false positives, false
negatives, interval cancers, removal of polyps detected by
colonoscopy, and detection of bowel cancer)
Bar chart displaying prevalence of mortality from bowel cancer in
Australia for men and women, comparison with other types of cancers.
Relative risk reduction statement about the efficacy of faecal occult
bloodtesting:“[FOBT]canreduceyourriskofdyingfrombowelcancerby
up to one third”
Values clarification exercise Interactive personal worksheet tailored for sex and family history
groups (see web extra appendix 2)
None
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as informed. The outcome was dichotomised to clas-
sifythosewith“adequate”andthosewith“inadequate”
knowledge for the informed choice measure.
Screening attitudes and behaviour
Attitudes towards completing the faecal occult blood
test were measured using a six item scale (with
response categories adapted from seven to five
categories).
25 Scores ranged from 6 to 30, with higher
scores denoting more positive attitudes towards doing
the test. The median value of the sample was used to
classify participants’ attitudes as positive or negative.
We assessed screening behaviour (completed test v
did not complete the test) three months post-inter-
vention from test completion records supplied by the
laboratory. The Australian government’s report on its
national bowel cancer screening programme showed
thatmostpeoplecompletethetestwithinthreemonths
of the first invitation.
13
Involvement preferences in screening decision
Weusedthecontrolpreferencesscaletodeterminethe
part that participants played or wanted to play in their
decisionaboutscreening.Thisscalerequirespeopleto
choose from one of five statements that best describes
how they (and their doctors) participated in the deci-
sion making process.
28
Secondary outcome measures
Secondary outcomes were decisional conflict (10 item
low literacy version of the decisional conflict scale
29),
decision satisfaction (10 item decision attitude scale
30),
confidence in decision making (three items adapted
from the decision self efficacy scale
31), general anxiety
(state trait anxiety inventory
32), interest in screening,
worry about developing bowel cancer,
33 and accept-
ability of materials.
34
Sample size
One of the primary outcomes of this study was knowl-
edge about the outcomes of screening using faecal
occult blood testing. To estimate the required sample
sizeforthecurrenttrialweusedresultsfromaprevious
generalpracticebasedtrialonadecisionaidforscreen-
ing using faecal occult blood testing.
24 Knowledge
scoresinthegeneralpracticebasedtrialwerenormally
distributed, with a mean of 2.72 (range −3 to 10) and
standarddeviationof2.35.Wecalculatedthattodetect
an improvement of 1 (that is, one extra knowledge
question answered correctly), with 90% power at the
1% significance level, required 165 participants in
each group. Allowing for 10% loss to follow-up after
randomisation,we aimedtorecruita totalof185parti-
cipants in each group (555 in total).
Statistical analysis
Analyses were by intention to treat and carried out
blinded to intervention. We used a paired sample t
testandWilcoxonsignedranktesttoassessdifferences
in knowledgescoresand decision makingpreferences,
respectively, within each group (pre-intervention v
post-intervention). Post-intervention comparisons
between the decision aid and control groups were
done using the independent sample t test for continu-
ousvariables,χ
2testforcategoricalvariables,andnon-
parametric Mann-Whitney test for ordinal variables.
We used the χ
2 test to compare between the groups
the proportion of people classified as making an
informedchoiceaboutscreening.Toexaminetherela-
tionbetweenriskofbowelcancer(basedonfamilyhis-
tory) and screening behaviour, we used the Mantel-
Haenszel test. All reported P values are two sided,
with P<0.05 considered as significant. Analyses were
carried out using SPSS version 17.0.
RESULTS
Of the 2850 potentialparticipants contacted, 675 were
eligible, of whom 572 (85%) consented to participate
and were randomised and interviewed at baseline. Of
these, 42 did not complete the follow-up telephone
interview becausethey eitherno longerwanted topar-
ticipate in the study (n=12) or were unavailable
because of family and other health concerns (n=30),
leaving a total of 530 (figure).
Baseline characteristics
Intervention and control groups had similar baseline
characteristics (table 2). Overall, 11% of participants
(62/572)reportedafamilyhistoryofbowelcancerand
70% (402/572) were interested in doing the screening
test. Participants’ conceptual understanding of the fae-
cal occult blood test (at baseline) was similar across all
three groups. Those lost to follow-up had significantly
poorer self reported health at baseline, which corre-
sponded with their reasons for not completing the fol-
low-up interview.
Primary analyses
Asthetwodecisionaidgroups(withandwithoutques-
tion prompt list) did not differ significantly, the two
groupswerecombinedandcomparedwiththecontrol
group.
Knowledge, attitudes, and screening behaviour
Conceptual knowledge improved significantly in both
groups before and after the intervention, with a mean
increase of 1.20 in the decision aid groups and 1.26 in
the control group (P<0.001). The proportion of parti-
cipants with adequate total knowledge (score ≥6 out of
12onthefullknowledgescale),however,washigherin
the decision aid groups than in the control group (56%
(200/357) v 19% (33/173); P<0.001). In particular, the
decision aid increased participants’ numerical under-
standing of their baseline risk of bowel cancer and the
absolute reduction in deaths attributable to screening:
the mean scores (maximum score 8) were 2.93 for the
decision aid groups and 0.58 for the control group, an
increase of 2.36 (P<0.001; table 3).
Participants in the decision aid groups were slightly
lesspositive thancontrols aboutscreeningusing faecal
occult blood testing; the mean scores were 26.4 for the
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(P=0.003).Atthreemonths,thedifferenceinscreening
behaviour was statistically significant. The proportion
of participants who had completed and returned the
screening test was 75% (130/173) in the control group
and 59% (211/357) in the decision aid groups
(P<0.001). The tailored information showed no effect,
with similar uptake rates in higher risk groups due to
positive family history. Overall, 68% (232/341) of par-
ticipants had completed the screening test by the time
they were interviewed at the two week follow-up tele-
phonecall.Thisissimilartopatternsofparticipationin
screening reported in the Australian national bowel
cancer screening programme, which indicates that
most screening participants who return a completed
faecal occult blood test kit do so within two to four
weeks of it being sent.
13
Informed choice
Participants’ knowledge, attitudes, and behaviour
were categorised according to Marteau’s multidimen-
sional model of informed choice (table 4).
25 The pro-
portionofparticipantsmakinganinformedchoicewas
22% higher in the decision aid groups than in the con-
trol group (34% (121/357) v 12% (21/172); P<0.001).
Furthermore, a higher proportion of participants who
received the government information (41% (71/172))
comparedwiththedecisionaid(15%(52/357))madea
“partly uninformed choice” about screening, complet-
ing the test with positive attitudes but inadequate
knowledge. There was, however, little difference
betweenthedecisionaidandcontrolgroupsintheper-
centage of participants making a “completely unin-
formed choice” (having inadequate knowledge and
inconsistent attitudes and behaviour). Decreasing and
increasing the pass mark or threshold for adequate
knowledge had little effect on this difference between
groups in the percentage of participants making an
informed choice. For example, by increasing the
knowledge pass mark to 75% (≥9 out of 12), the differ-
ence remained about the same, at 20%.
Involvement preferences in screening decision
Aftertheinterventionbothgroupsshowedasignificant
shift towards more active involvement in decision
making (P<0.001). Most participants reported making
thedecisionontheirown(decisionaid90%(320/355)v
control96%(164/171))comparedwiththeirstatedpre-
intervention preference for involvement in decision
making(37%(143/384)and41%(78/188)).Compared
with the control group, however, participants in the
decisionaidgroupsshowedasignificanttrendtowards
sharingorpreferringtosharethedecisionwiththeclin-
ician (trend,P=0.04). From a proportionalodds model
it was estimated that participants in the decision aid
groups were 2.5 times more likely to share or prefer
to share the decision with the clinician (odds ratio
2.47, 95% confidence interval 1.07 to 5.69).
Secondary analyses
Decision quality and psychosocial outcomes
Table5presentstheimpactofthebookletsondecisional
quality and psychosocial outcomes.
The total decisional conflict scores (maximum score
100) were significantly lower (P=0.02) in the decision
aidgroups(median0,nodecisionalconflict)thaninthe
control group (median 10); the means were 13.63 (SD
20.55) and 14.91 (SD 18.34), respectively. More parti-
cipants in the decision aid groups than in the control
group had low decisional conflict overall about the
Respondents contacted through New South Wales electoral roll (n=2850)
Randomised (n=572)
Decision aid + question prompt list (n=196) Decision aid + DVD (n=188) Standard information (n=188)
Eligible for informed
choice analysis (n=177)
Eligible for informed
choice analysis (n=180)
Eligible for informed
choice analysis (n=172)
One participant refused to
complete the attitude measure
Respondents excluded (n=2278):
  Did not meet inclusion criteria (n=1524)
Allocation
Follow-up telephone interview at two weeks
  (n=177)
Lost to follow-up (n=19):
  Unavailable – health or family problems
    (n=12) 
  Personal refusal (n=7)
Follow-up telephone interview at two weeks
  (n=180)
Lost to follow-up (n=8):
  Unavailable – health or family problems
    (n=7)
  Personal refusal (n=1)  
Follow-up telephone interview at two weeks
  (n=173)
Lost to follow-up (n=15):
  Unavailable – health or family problems
    (n=11)
  Personal refusal (n=4) 
Follow-up
Analysis
An error occurred in randomisation at the end of the trial whereby seven consecutive participants were allocated to the decision aid and question prompt list group, 
of whom five completed the follow-up telephone interview
Flow of participants through trial
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controlgroup(51%(181/357)v38%(65/173);table 5).
Thiswasprimarilyduetomoreparticipantsinthedeci-
sion aid groups (65% (233/357)) feeling informed
about the decision and the potential benefits and
harms of screening (informed subscale) than partici-
pants in the control group (52% (90/173); P=0.03).
The groups did not differ significantly in how satis-
fied (P=0.49) or confident (P=0.91) they were in their
decision making. The decision aid did not increase
Table 2 |Baseline characteristics of participants (n=572) allocated to decision aid intervention (with and without question
prompt list) and standard information (control group)
Characteristics
No (%)
Decision aid+question
prompt list (n=196)
Decision aid+DVD
(n=188)
Standard information
(n=188)
Women 97 (50) 93 (50) 94 (50)
Men 99 (51) 95 (51) 94 (50)
Education:
No formal qualifications 4 (2) 4 (2) 6 (3)
Intermediate school certificate* 132 (67) 129 (69) 131 (70)
Technical or trade certificate† 64 (33) 59 (31) 57 (30)
Years in full time education:
0-10 116 (59) 106 (56) 107 (57)
11-20 78 (40) 81 (43) 79 (42)
Country of birth:
Australia or New Zealand 177 (90) 162 (86) 158 (84)
United Kingdom 11 (6) 16 (9) 9 (5)
Other 8 (4) 10 (5) 21 (11)
Difficulties understanding written health information:
Never 64 (33) 62 (33) 56 (30)
Occasionally or sometimes 102 (52) 113 (60) 118 (63)
Often or always 29 (15) 11 (6) 12 (6)
Confidence filling in medical forms:
None 38 (19) 35 (19) 24 (13)
Some or quite a bit 108 (55) 99 (53) 114 (61)
Very 50 (26) 54 (29) 49 (26)
Help with reading hospital forms:
Never 103 (53) 100 (53) 115 (61)
Occasionally or sometimes 57 (29) 56 (30) 44 (23)
Often or always 23 (12) 14 (7) 15 (8)
Not applicable 13 (7) 18 (10) 14 (7)
Self reported health:
Excellent or very good 98 (50) 80 (43) 93 (50)
Good 71 (36) 69 (37) 54 (29)
Fair or poor 35 (18) 39 (21) 41 (22)
Family history of bowel cancer:
Yes 25 (13) 16 (9) 21 (11)
No 167 (85) 167 (89) 164 (87)
Worry about developing bowel cancer:
None or a bit 170 (91) 184 (94) 172 (92)
Quite or very 17 (9) 11 (6) 16 (9)
Interest in screening using faecal occult blood test:
Very or fairly 136 (69) 135 (72) 131 (70)
A bit or not very 57 (29) 49 (26) 51 (27)
Preferences for involvement in screening decision:
Patient decides alone 68 (35) 75 (40) 78 (41)
Patient decides after consulting 41 (21) 28 (15) 39 (21)
Share decision equally 72 (37) 70 (37) 54 (29)
Doctor decides after consulting or alone 13 (7) 14 (8) 21 (7)
Knowledge scores (maximum 4)‡:
Mean (SD) 2.37 (1.62) 2.32 (1.53) 2.23 (1.64)
*Certificate awarded to students aged 15 or 16 years in Australian high school.
†Approximately equivalent to national vocational qualification in United Kingdom.
‡Conceptual knowledge was only measured at baseline.
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cer. Thegroups didnot differ significantlyin ratingsof
clarity (P=0.10) and helpfulness of the information
(P=0.87). Most of the participants in each group
reported reading all of the booklet (decision aid 78%
(263/337) v control 75% (125/167)), and thought the
information was clear (decision aid 98% (330/336) v
control 100% (167/167)) and helpful (decision aid
96% (324/336) v control 97% (162/167)) in their deci-
sion making. A few more participants in the decision
aid groups perceived the information as being
balanced and fair compared with participants in the
control group, but this was not significant (48% (160/
334) v 41% (67/164); P=0.22). Only one participant
used the question prompt list to talk to their doctor
about the screening test. Nearly half (47% (166/357))
of participants in the decision aid group said they
viewed the DVD. Of these, most (72% (119/166))
watched it after reading the booklet, found it clear
andeasytofollow(97%(161/166))andhelpfulinmak-
ing a decision about screening (96% (160/166)). Over-
all, there was no evidence of an interactive effect
betweenrisk of bowelcancer (based onfamily history)
and completion of the test (Mantel-Haenszel P=0.99).
DISCUSSION
A tailored decision aid can be effective in supporting
adults with low education to make an informed choice
about screening using faecal occult blood testing. The
decision aid significantly increased participants’
knowledge about the cumulative outcomes of such
screening,withoverhalfshowingsufficientknowledge
for making an informed decision. In particular, the
decision aid improved understanding about the num-
ber of people who die naturally from bowel cancer
without screening (baseline risk) and the number of
lives saved by screening (absolute risk reduction).
Importantly,theproportionofparticipantsinthedeci-
sion aid groups who made an informed choice about
screening increased by 22%, from 12% in the control
group to 34% in the decision aid group. This was con-
firmed by significantly lower levels of decisional con-
flict in the decision aid group than among controls,
which was primarily due to them feeling more
informed about their decision and the potential bene-
fits and harms of screening.
Althoughthedecisionaiddidnotmakepeoplemore
worried about developing bowel cancer, it did make
them feel less positive about screening, and reduced
uptakeofthescreeningtestby16%(75%inthecontrol
group v 59% in the decision aid groups). It seems that
this may have resulted from increasing their knowl-
edge about the low personal benefit of screening.
Overall,mostparticipantsreportedmakingthescreen-
ing decision on their own (without consulting a health
professional), irrespective of which intervention they
hadread.However,theresultsindicatedthatclarifying
to the reader that they have a choice about screening,
making them aware of the possible limitations and
downsidesofscreening,andadvisingthemtoconsider
how they value each outcome, did encourage some
participants in the decision aid groups compared with
the control group to share or prefer to share the deci-
sion with their doctor.
Strengths and limitations of the study
The strengths of the study include its design (a rando-
mised controlled trial), similar baseline characteristics
acrossgroups,and goodrecruitment (consent)andfol-
low-up rates (84% and 98%, respectively). The high
Table 3 |Primary outcomes for decision aid intervention groups combined and standard information (control) group. Values are numbers (percentages)
unless stated otherwise
Outcome*
Decision aid groups combined
(n=357)
Standard information group
(n=173)
Difference (decision aid
−control) (95% CI) P value
Knowledge scores (mean, SD)†:
Concept (maximum score 4) 3.57 (1.0) 3.53 (0.96) 0.04 (−0.14 to 0.22) 0.64
Numerical (maximum score 8) 2.93 (2.91) 0.58 (1.28) 2.35 (1.89 to 2.80) <0.001
Total knowledge score (maximum score 12) 6.50 (3.34) 4.10 (1.71) 2.39 (1.86 to 2.92) <0.001
Adequate knowledge (total score ≥50%) 200 (56) 32 (19) 37.5 (30.0 to 45.0) <0.001
Attitudes‡:
Mean (SD) score 26.4 (3.6) 27.3 (2.7) −0.91 (−1.51 to −0.31) 0.003
Positive attitudes towards screening 182 (51) 112 (65) −14.1 (−23.0 to −5.0) 0.002
Completed screening test§ 211 (59) 130 (75) −16.0 (−24.0 to −8.0) <0.001
Informed choice 121 (34) 21 (12) 22.0 (15.0 to 29.0) <0.001
Involvement preferences in screening decision¶:
Participant decides alone 321 (90) 164 (96) −5.5
0.04**
Participant decides after consulting doctor 14 (4) 2 (1) 2.7
Share decision equally 17 (5) 5 (3) 1.9
Doctor decides after consulting or alone 3 (1) 0 (0) 0.9
*For some variables a small proportion of data was missing (between 1 and 3 cases).
†Maximum concept and numerical knowledge score, 4 and 8, respectively; maximum total knowledge score, 12.
‡Attitudes scale 6-30: the higher the score, the more positive the attitude towards bowel cancer screening. Scores ≥27 (median) were taken to indicate positive attitudes.
§Determined from laboratory records checked three months post-intervention.
¶Values for difference are percentages.
**P value for test for trend in proportions.
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mitted (bythe universityresearchethics committee)to
telephone respondents directly, rather than recruiting
by written communication. Opt-in methods (through
written correspondence) have been shown to deter
groupswithloweducationandliteracyfromparticipat-
inginresearch.
3536Giventhehighrecruitmentandfol-
low-up rates, we are confident that our sample is
representative of the target audience and that the
results are generalisable to adults with low education
in the wider community. However, it is important to
note that it was not specifically tested among a sample
with measured levels of low literacy, which means the
results may be an overestimate of the effect when gen-
eralised to adults with basic levels of literacy.
The trial also did not test the impact of the decision
aid among socially advantaged groups and therefore it
is unclear how the decision aid would have influenced
informed choice and involvement in a sample with
higher education. We know from trials of health lit-
eracy interventions that in some circumstances inter-
ventions have been effective in higher education and
literacy groups but not in lower education and literacy
groups.
37 We think it is likely the decision aid will be
understood by a better educated group and will sup-
port informed choice. However, we cannot predict
the effect on screening behaviour or attitudes among
a better educated population. Some researchers have
suggested that information about harms may differen-
tially dissuade lower education groups compared with
their higher educated counterparts from carrying out
preventive health behaviour since it encourages a
focus on immediate harmful consequences and may
biasparticipantswithlowereducationawayfromvalu-
ing future benefits.
38 If this proposition stands we may
not observe the same attitude and behaviour effect of
thedecisionaidinabettereducatedsample.However,
this currently remains unknown.
Telephone interviews were considered the most
appropriatestrategytorecruitandinterviewalowedu-
cation and literacy sample, since this group may
experience difficulties completing written question-
naires. Although this data collection method is highly
suitable for adults with low literacy, the personal tele-
phone call may have encouraged participants to feel
obliged to read and process the decision aid or control
material.Thisisdifferentfromtypicalinvitationsorga-
nised by bowel cancer screening programmes outside
of a research setting. This feature of the data collection
process potentially reduces the extent to which the
results can be generalised to how people may behave
if they were sent the decision aid within the context of
an organised screening programme without a tele-
phone interview.
Oneofthestrengthsofthisstudyisitsstronginternal
validity, which is important for an efficacy (phase III)
trial of this nature. A different design would be
required for an implementation (phase IV) trial. It
would be useful to carry out a further trial in which
only participation in screening is measured from
laboratory records as a result of the decision aid, and
participants are not followed-up personally after they
receive the intervention. However, since this was the
first randomised trial to assess the effect of a decision
aid in a low education sample, we considered it essen-
tial to measure a range of primary and secondary out-
comes,includinginformedchoice,usingamethodthat
wasunderstandableandassuredareasonableresponse
rate from the target sample. This meant that partici-
pants were telephoned for a follow-up interview and
asked a battery of questions. We note that most pub-
lishedtrialsondecisionaidsusedesignsthatpersonally
follow-up participants to assess the impact of the deci-
sion aid, and that if we had not done this we would not
have known whether the decision aid supported
informed choice, which was a fundamental objective
of this trial.
Another strength of this research is that we devel-
oped and evaluated the decision aid intervention in
accordance with the International Patient Decision
AidStandards,whicharedesignedtoensureaminimal
level of quality for decision aids and are currently
under revision.
2339 Although this approach is widely
used by developers of decision aids, we recognise that
the role of using criteria set out in the International
Patient Decision Aid Standards (or checklists) to
Table 4 |Distribution of informed or uninformed choices for decision aid and control groups. Values are numbers (percentages) unless stated otherwise
Choices and preferences for screening
Adequate
knowledge
Positive
attitudes Uptake
Decision aid groups
combined (n=357)
Standard information
group (n=172)
% Difference (decision aid
−control) (95% CI)
Informed choice: 120 (34) 20 (12) 22 (15 to 29)
Accept Yes Yes Yes 72 (20) 18 (11) 11 (4 to 16)
Decline Yes No No 48 (13) 2 (1) 12 (8 to 13)
Partly uninformed choice*:
Accept Yes No Yes 51 (14) 9 (5) 9 (2 to 16)
Decline Yes Yes No 29 (8) 3 (2) 6 (3 to 10)
Accept No Yes Yes 52 (15) 71 (41) −26 (−35 to −19)
Decline No No No 40 (11) 17 (10) 1 (−4t o7 )
Completely uninformed choice†:
Accept No No Yes 36 (10) 32 (19) −9( −15 to 2)
Decline No Yes No 29 (8) 20 (12) −4( −6t o2 )
*Adequate knowledge or consistent attitudes and behaviour.
†Inadequate knowledge and inconsistent attitudes and behaviour.
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since it is unclear whether decision aids that comply
with these criteria are more effective than those that
do not.
40
Although the current trial generates evidence that
the decision aid was effective in helping adults with
low education to make an informed choice about
screening,itonlyprovidesapartialpictureofthecapa-
city of the intervention. Other issues are important,
such as how the intervention was used and why it
affected decision making.
41 To tackle this we carried
out a qualitative interview study with a subsample of
participants to explore in-depth how they used the
decision aid and made their decision about screening.
This has enabled us to explore in more detail which
specific elements of the interventions (for example,
riskinformationandexercisestoclarifypatientvalues)
were used and how they influenced participants’ deci-
sion making and screening behaviour. This is to be
reported later.
Comparison with other studies
It is difficult to compare our results with those of pre-
vious trials on decision aids as most provide limited
details on how they assessed knowledge or did not
measure informed choice. In terms of knowledge,
onestudyfoundthattheprovisionofabsoluteandrela-
tive risk information (compared with no risk informa-
tion) increased understanding about the positive
predictive value of screening for bowel cancer by
17%.
42 Other similar work has shown improvements
in the proportion of participants (receiving a decision
aid) having adequate knowledge about screening out-
comes, by 15%
24 and 20%.
27 In the current trial, ade-
quate knowledge increased by 38%, twice the amount
shown in previous studies.
With regard to informed choice, a general practice
based trialofa decisionaid forfaecal occultbloodtest-
ing increased the proportion who made an informed
decision by 8%, from 2% to 10%.
24 A mammography
screening decision tool for women aged 70 years also
enabled 25% more women to make an informed
choice about whether to continue screening (49% in
controlgroupv74%indecisionaidgroup).
27Similarly,
in the current study, the absolute difference in the pro-
portion who made an informed choice was 22% (12%
in control group and 34% in decision aid group).
Inthisstudy,thedecisionaidresultedinasignificant
reduction in the number of people completing the
screening test. Previous work has found that decision
aids do not affect screening intentions or
participation,
242742-44 although one decision aid trial
found a 14% increase (from 23% to 37%) in screening
participation in patients who received a video based
decision aid.
45 The tool, however, offered patients a
choice between screening tests (for example, faecal
occult blood testing, flexible sigmoidoscopy, colono-
scopy), and did not seem to present the option of no
screening. Furthermore, healthcare staff were not
blinded to the group allocation and may have poten-
tially tried to encourage more patients in the decision
aid group to screen.
Several possible reasons may have resulted in the
reduced uptake of faecal occult blood testing. Unlike
existing national programmes for breast and cervical
cancer screening, screening programmes using faecal
occultbloodtestingarerelativelynewinAustralia(and
in the United Kingdom) and have not attracted the
sameamountofmediacoverageorwidespreadprofes-
sional and public support. It is likely that most people
have not been as exposed to traditional information
designed to encourage screening using faecal occult
blood testing, suggesting that public awareness and
Table 5 |Secondary outcomes for decision aid intervention groups combined and control
group. Values are numbers (percentages) unless stated otherwise
Outcome*
Decision aid groups
combined (n=357)
Standard
information group
(n=173)
Difference (decision
aid−control) (95% CI) P value
Mean (SD) decision
satisfaction
†
4.21 (0.44) 4.21 (0.43) 0.00 (−0.09 to 0.08) 0.91
Mean(SD)confidencein
decision making
‡
4.67 (0.54) 4.61 (0.62) 0.06 (−0.04 to 0.16) 0.26
Mean (SD) anxiety
§ 28.20 (9.75) 28.43 (10.56) −0.23 (−0.62 to 0.45) 0.80
Decisional conflict¶ ¶
Total score: 0.02**
0 181 (51) 65 (38) 13
1-25 101 (28) 73 (42) −14
>25 75 (21) 35 (20) 1
Informed subscale: 0.03**
0 233 (65) 90 (52) 13
1-25 22 (6) 13 (8) −2
>25 102 (29) 70 (41) −12
Uncertainty subscale: 0.89**
0 275 (77) 134 (78) −1
1-25 15 (4) 5 (3) 1
>25 67 (19) 34 (20) −1
Values clarity subscale: 0.99**
0 276 (78) 134 (78) 0
1-25 22 (6) 8 (5) 1
>25 59 (17) 31 (18) −1
Support subscale: 0.38**
0 280 (78) 130 (75) 3
1-25 13 (4) 7 (4) 0
>25 64 (18) 36 (21) −3
Worry about developing
bowel cancer:
0.78††
None or a bit 335 (94) 159 (92) 2
Quite or very 22 (6) 14 (8) −2
Change in worry: 0.89††
Less worried 50 (14) 24 (14) 0
No change 252 (71) 121 (70) 1
More worried 54 (15) 27 (16) −0.5
*For some variables a small proportion of data was missing for a maximum of 23 participants.
†10 item scale. Participants who did not answer more than five of the items were excluded from analysis.
‡Three item scale. Participants who did not answer more than one of the items were excluded from analysis.
§State trait anxiety inventory (short form) 6 item scale: 20-80, the higher the score, the greater the level of
anxiety.
¶Decisional conflict scale (low literacy version): 0-100; 0=no decisional conflict; 100=extreme decisional
conflict. Subscales: 0-100, where 0=extremely certain about best choice, extremely informed, extremely clear
about personal values in relation to benefits or harms, extremely supported in decision making. Scores of 25 or
lower are associated with implementing decisions.
29 Values for difference are percentages.
**Mann-Whitney U test.
††P value for test for trend in proportions.
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well established as other cancer screening pro-
grammes.Inthesecircumstancesitmaynotbesurpris-
ing that presenting unbiased information on screening
and explaining that a choice exists, affected attitudes
and behaviour towards screening using faecal occult
blood testing.
Most trialson decision aids for bowel cancer screen-
ing have been done in general practice settings where
interventionsaretypicallydeliveredtopatientsattend-
ingprescheduledconsultations.Patientsmaytherefore
onlyhaveashortperiodtoprocesstheinformationand
mayhavesomedifficultydecliningthetestthatisbeing
offered, without considering how they feel about it in
relation to their values. Self administered (take home)
decision aids may therefore be an effective strategy to
help patients fully understand their options and make
informed decisions in line with their preferences, with
additional time and away from influence.
Another possible explanation for differences in
screening uptake relates to the presentation of the risk
information.Wepaidcarefulattentiontotherepresenta-
tion of population risks and benefits of screening (see
webextraappendix1)followingourqualitativeresearch
with low literacy groups, which indicated that popula-
tion diagrams were difficult to understand.
22 This may
have enhanced understanding of these elements of the
decision aid compared with other trials. The govern-
ment screening booklet contained information about
the effectiveness of screening using faecal occult blood
testing presented in relative risk format: “[FOBT] can
reduce your risk of dying from bowel cancer by up to
one third,” whereas the decision aid included persona-
lised, absolute risk information, comparing the out-
comes of screening with no screening. Communicating
screening outcomes using relative risk format is well
recognised as inappropriate to support understanding
of information on the risks and benefits of screening, as
it is associated with overestimating the benefits.
4647
Indeed, qualitative interviews with our trial participants
were consistent with previous findings that the relative
risk format was more persuasive than the absolute risk
format. Relative risk information may create unrealistic
expectations about the effectiveness of screening using
the faecal occult blood test on mortality from bowel
cancer, and influence screening decisions in favour of
participation. In establishing population screening pro-
grammes careful consideration needs to be given to the
possibleimplicationsofframinginformationinthisway,
as it may reinforce public misconceptions about
screening.
12
Almost all trials on decision aids (including the cur-
rentone)focusontheshorttermimpactofthedecision
aidondecisionmaking,ratherthantheeffectonhealth
and quality of life outcomes over a longer period.
Debate is ongoing about the appropriateness of deci-
sion quality measures such as decisional conflict and
satisfaction, which have typically been used to assess
theeffectivenessofdecisionaids.Inthecurrenttrialwe
measured decisional conflict as a secondary outcome.
Participants obtained low scores on the decision
conflict scale (which has traditionally been considered
to be a “good” indicator of quality in the decision pro-
cess) and the intervention groups did not differ. How-
ever, it is currently unknown whether low decisional
conflict scores correspond with “better” decision mak-
ing, and it has been suggested that higher scores may
meanthatpeopledeliberatemorecarefullyabouttheir
options.
48 At present we have no data to indicate
whether low or high decisional conflict is optimal.
Similarly, participants’ anxiety scores (as measured
by the state trait anxiety inventory) were also low and
nodifferenceswereobservedbetweenthedecisionaid
and control groups. Our motivation to include this
measure was to ensure that we did not, by the use of
the decision aid and offer of choice, cause undue anxi-
ety to participants at the time of decision making. Our
results show that we did not. However, it should be
noted that although short term anxiety was low, we
do not know the effect on anxiety in the long term.
49
Future research should investigate the extent to
whichdecisionaidsinfluenceboththedecisionmaking
process and longer term outcomes in relation to
patients’ quality of life, wellbeing, survival, and
function.
50
Policy implications and future research
Thisstudyshowsthatthe decisionaid maybeaneffec-
tive way to support a screening policy that values
informed choice and equity in access to informed
choice, as opposed to policy focused on achieving
high uptake. These results present an important
dilemma for policy makers and healthcare providers
onhow tocommunicate to the public aboutscreening.
Governments in Australia, the United Kingdom, and
many other countries have advocated patient engage-
mentindecisionmakingandinformedchoice.
5152Tra-
ditionally, governments have encouraged the uptake
of screening for the public good, placing a greater
emphasis on the benefits of participating, such as
reduced mortality and morbidity.
53 This is also under-
pinned by a belief that greater uptake leads to more
costeffectivescreeningprogrammesandconsequently
high uptake rates remain an important target for such
screeningproviders.Studieshavenowshownthathigh
participation doesnot necessarilyguaranteecost effec-
tiveness in screening programmes, especially if the
programme does not have large set-up costs.
54 Indeed,
supportinginformedchoicein bowelcancerscreening
isunlikely toreduce cost effectivenessand in some cir-
cumstances may actually increase it.
55 Furthermore, if
informed choice, as set out by the General Medical
Council, is to be adopted and promoted as a goal of
high quality health care, it must be available to a
broadspectrumofthecommunitysotheymayequally
exercise informed choice.
One study has put forward an alternative approach
(as “consider an offer”) to communicating about
screening.
56 Withinthis approach,providershelp peo-
ple to carefully consider a screening recommendation
or offer. This involves the provider clearly explaining
to the individual why screening is being offered or
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judgmentsaboutthetrustworthinessoftherecommen-
dationor offer;providingfurtherinformation,if thatis
desired, about the outcomes or other people’s prefer-
ences (for example, evidence based information about
the benefits and harms of a screening intervention);
and recognising that people might want to decline the
recommendation or offer. This flexible approach
allows people to respond to the screening invitation
in a way that suits them best. For example, some may
want to access more detailed information about the
various outcomes of screening (as typically presented
in a decision aid), whereas others may simply prefer to
followtherecommendationsoftrustedhealthcarepro-
viders. Thus this approach does not expect people to
assess the credibility of research evidence by them-
selves nor does it restrict decision making to simply
adhering to professional guidelines. This may provide
athirdwayforscreeningprovidersseekingtoreconcile
informedchoicewithtraditionalapproachestoscreen-
ing participation.
Despite growing evidence that decision aids are
effective in supporting decision making, their use in
everyday clinical practice is limited.
57 Although
healthcare practitioners may support the notion of
using decision aids, they often report that they do not
haveenoughtimetoadministerthetoolduringconsul-
tations and express concerns that it may adversely
affect the doctor-patient relationship.
58 Investigating
possibleways in which the decision aid could bedeliv-
ered into the wider community to people from a range
of different education and literacy backgrounds is a
priority for future research. We believe the decision
aid could be made available to participants through
general practitioners or national screening providers
as a web or paper based tool. In our trial the paper
based decision aid was sent with the faecal occult
blood test kit to participants eligible for screening at
home to read and complete as they wished. In this
way, we reflected the current screening programme
practice. Both the United Kingdom and Australia
have mail based bowel screening programmes, with
test kits sent to eligible participants’ homes. Further
testing of alternative implementation strategies for a
decisionaidsuchasthisonewouldbeusefulinafuture
pragmatic trial.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Patient decision aids increase knowledge and involvement in decision making, without
increasing decisional conflict or anxiety
Researchhasnotexaminedtheimpactofdecisionaidsamongadultswithloweducationand
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